SCHEMBL2264166

SCHEMBL2264166

NC(=O)c1n[nH]cc1NCCCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.49
ALDH1A1 P00352 5/20 0.49
MAPT P10636 5/20 0.49
MEN1 O00255 5/20 0.49
NPC1 O15118 3/20 0.49
TSHR P16473 3/20 0.49
MAPK1 P28482 2/20 0.49
TRPA1 O75762 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CDK2 P24941 1/20 0.49
THPO P40225 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
HSD17B10 Q99714 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
PKM P14618 2/20 0.47
HPGD P15428 1/20 0.45
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268996 0.84 RPS6KB1 (0.39) HDAC6KDM4E
SCHEMBL2264170 0.78 CYP2D6 (0.45) KMT2AALDH1A1MAPTMEN1NPC1
SCHEMBL27778811 0.78 MAPT (0.55) KMT2AALDH1A1MAPTMEN1NPC1
SCHEMBL2264927 0.77 RPS6KB1 (0.40) KMT2AALDH1A1MAPTMEN1PKM
SCHEMBL5096930 0.73 ALDH1A1 (0.54) KMT2AALDH1A1MAPTMEN1NPC1
SCHEMBL2264213 0.72 ACHE (0.46) ALDH1A1MAPTNPC1TSHRLMNA
SCHEMBL12473704 0.71 KMT2A (0.58) KMT2AALDH1A1MAPTMEN1NPC1
SCHEMBL2264162 0.71 CYP2D6 (0.47) KMT2AALDH1A1MAPTMEN1NPC1
SCHEMBL2264874 0.70 RPS6KB1 (0.50) NPC1CDK2RAB9AATM
Trifluoroacetic Acid SCHEMBL1075601 0.69 ALDH1A1 (0.48) KMT2AALDH1A1MAPTMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420824-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI (FR) 2013-04-16 US disclosed
US-8410286-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2013-04-02 US disclosed
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-7989439-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2011-08-02 US disclosed
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 KMT2A 2593/4885ALDH1A1 354/4885MAPT 2805/4885
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE CYP4B1, ADORA1, CYP1B1 KMT2A 2544/4885ALDH1A1 242/4885MAPT 2843/4885
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 KMT2A 2593/4885ALDH1A1 354/4885MAPT 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.